Chen XW et al. |
Isoflavones regulate interleukin-6 and osteoprotegerin synthesis during osteoblast cell differentiation via an estrogen-receptor-dependent pathway. |
2002 |
Biochem. Biophys. Res. Commun. |
pmid:12150965
|
Hofbauer LC et al. |
Regulation of osteoprotegerin production by androgens and anti-androgens in human osteoblastic lineage cells. |
2002 |
Eur. J. Endocrinol. |
pmid:12153751
|
Mundy GR |
Metastasis to bone: causes, consequences and therapeutic opportunities. |
2002 |
Nat. Rev. Cancer |
pmid:12154351
|
Lorget F et al. |
Lactoferrin reduces in vitro osteoclast differentiation and resorbing activity. |
2002 |
Biochem. Biophys. Res. Commun. |
pmid:12163011
|
Geoffroy V et al. |
High bone resorption in adult aging transgenic mice overexpressing cbfa1/runx2 in cells of the osteoblastic lineage. |
2002 |
Mol. Cell. Biol. |
pmid:12167715
|
Uemura H et al. |
Serum osteoprotegerin/osteoclastogenesis-inhibitory factor during pregnancy and lactation and the relationship with calcium-regulating hormones and bone turnover markers. |
2002 |
J. Endocrinol. |
pmid:12176675
|
Ragab AA et al. |
Cytokines synergistically induce osteoclast differentiation: support by immortalized or normal calvarial cells. |
2002 |
Am. J. Physiol., Cell Physiol. |
pmid:12176725
|
Ulrich-Vinther M et al. |
Recombinant adeno-associated virus-mediated osteoprotegerin gene therapy inhibits wear debris-induced osteolysis. |
2002 |
J Bone Joint Surg Am |
pmid:12177271
|
Ohmori H et al. |
Linkage and association analyses of the osteoprotegerin gene locus with human osteoporosis. |
2002 |
J. Hum. Genet. |
pmid:12181640
|
Armstrong AP et al. |
A RANK/TRAF6-dependent signal transduction pathway is essential for osteoclast cytoskeletal organization and resorptive function. |
2002 |
J. Biol. Chem. |
pmid:12185073
|
Cundy T et al. |
A mutation in the gene TNFRSF11B encoding osteoprotegerin causes an idiopathic hyperphosphatasia phenotype. |
2002 |
Hum. Mol. Genet. |
pmid:12189164
|
Lee SK et al. |
1,25(OH)2 vitamin D3-stimulated osteoclast formation in spleen-osteoblast cocultures is mediated in part by enhanced IL-1 alpha and receptor activator of NF-kappa B ligand production in osteoblasts. |
2002 |
J. Immunol. |
pmid:12193704
|
Fujita T et al. |
SPARC stimulates the synthesis of OPG/OCIF, MMP-2 and DNA in human periodontal ligament cells. |
2002 |
J. Oral Pathol. Med. |
pmid:12201246
|
Juji T et al. |
A novel therapeutic vaccine approach, targeting RANKL, prevents bone destruction in bone-related disorders. |
2002 |
J. Bone Miner. Metab. |
pmid:12203031
|
Jono S et al. |
Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease. |
2002 |
Circulation |
pmid:12208791
|
Sedger LM et al. |
Characterization of the in vivo function of TNF-alpha-related apoptosis-inducing ligand, TRAIL/Apo2L, using TRAIL/Apo2L gene-deficient mice. |
2002 |
Eur. J. Immunol. |
pmid:12209637
|
Hofbauer LC et al. |
Detection and characterization of RANK ligand and osteoprotegerin in the thyroid gland. |
2002 |
J. Cell. Biochem. |
pmid:12210731
|
Kondo H et al. |
Cyclic adenosine monophosphate/protein kinase A mediates parathyroid hormone/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells. |
2002 |
J. Bone Miner. Res. |
pmid:12211438
|
Hofbauer LC and Schoppet M |
Osteoprotegerin gene polymorphism and the risk of osteoporosis and vascular disease. |
2002 |
J. Clin. Endocrinol. Metab. |
pmid:12213849
|
Arko B et al. |
Sequence variations in the osteoprotegerin gene promoter in patients with postmenopausal osteoporosis. |
2002 |
J. Clin. Endocrinol. Metab. |
pmid:12213850
|